Profile data is unavailable for this security.
About the company
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
- Revenue in CNY (TTM)26.83bn
- Net income in CNY1.14bn
- Incorporated1999
- Employees43.53k
- LocationDaShenLin Pharmaceutical Group Co LtdNo. 410410-1, Longxi Avenue, Liwan DistrictGUANGZHOU 510000ChinaCHN
- Phone+86 2 081689688
- Fax+86 2 081176091
- Websitehttps://www.dslyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genky DrugStores Co Ltd | 9.46bn | 349.97m | 6.43bn | 1.84k | 18.06 | 2.45 | 9.89 | 0.6796 | 256.34 | 256.34 | 6,928.04 | 1,891.26 | 1.66 | 6.05 | 47.17 | 114,768,600.00 | 6.15 | 5.34 | 9.42 | 8.48 | 20.47 | 20.47 | 3.70 | 3.22 | 0.2809 | 48.77 | 0.3793 | 6.99 | 8.62 | 10.19 | 11.73 | 20.73 | 6.54 | 0.7875 |
| MedPlus Health Services Ltd | 4.99bn | 157.92m | 8.19bn | 25.00k | 51.87 | -- | 22.42 | 1.64 | 17.25 | 17.25 | 544.80 | -- | -- | -- | -- | 2,615,076.00 | -- | 3.44 | -- | 4.32 | 26.24 | 22.31 | 3.17 | 1.83 | -- | 2.67 | -- | 0.00 | 9.09 | 16.41 | 129.59 | 133.19 | 14.50 | -- |
| Dashenlin Pharmaceutical Group Co Ltd | 26.83bn | 1.14bn | 22.26bn | 43.53k | 19.53 | 3.08 | -- | 0.8297 | 1.00 | 1.00 | 23.86 | 6.35 | 1.03 | 4.28 | 22.02 | 616,415.10 | 4.72 | 5.62 | 10.67 | 11.14 | 33.97 | 36.48 | 4.57 | 5.00 | 0.6584 | 12.56 | 0.4131 | 51.24 | 8.01 | 18.92 | -21.58 | 5.42 | 24.10 | 16.46 |
| Yifeng Pharmacy Chain Co Ltd | 24.13bn | 1.64bn | 30.77bn | 40.02k | 19.08 | 2.75 | -- | 1.28 | 1.33 | 1.33 | 19.54 | 9.22 | 0.9057 | 3.51 | 15.33 | 602,957.60 | 6.66 | 6.75 | 12.23 | 12.46 | 39.73 | 38.98 | 7.36 | 6.83 | 1.01 | 67.62 | 0.2836 | 28.44 | 6.53 | 18.55 | 8.26 | 22.96 | 8.50 | 45.96 |
| MatsukiyoCocokara & Co | 48.57bn | 2.52bn | 48.37bn | 12.75k | 18.81 | 2.01 | 13.62 | 0.9958 | 140.02 | 140.02 | 2,702.11 | 1,312.37 | 1.52 | 4.78 | 17.57 | 85,077,310.00 | 7.95 | 6.89 | 10.48 | 8.96 | 35.16 | 34.03 | 5.21 | 4.74 | 1.33 | -- | 0.0027 | 29.83 | 3.82 | 12.44 | 4.45 | 15.87 | 18.34 | 13.53 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 32.95bn | 1.93bn | 87.79bn | 1.36k | 45.63 | 4.99 | 44.34 | 2.66 | 0.1346 | 0.1346 | 2.30 | 1.23 | 1.52 | 13.46 | 31.11 | 27,331,260.00 | 8.86 | 3.19 | 11.64 | 4.20 | 24.48 | 22.21 | 5.84 | 2.43 | 2.34 | -- | 0.0043 | 0.00 | 13.22 | 26.10 | 62.14 | -- | 6.95 | -- |
Data as of Feb 11 2026. Currency figures normalised to DaShenLin Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 31.49m | 2.77% |
| Lazard Asset Management LLCas of 31 Dec 2025 | 31.39m | 2.76% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 11.69m | 1.03% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 7.17m | 0.63% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 4.34m | 0.38% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 3.93m | 0.35% |
| FIL Investment Management (Singapore) Ltd.as of 31 Oct 2025 | 3.21m | 0.28% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.98m | 0.26% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 2.84m | 0.25% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.82m | 0.25% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
